<?xml version="1.0" encoding="UTF-8"?>
<p id="par0015">Colchicine has been used for more than 10 years for symptomatic treatment of patients with iatrogenic allogenosis (IA), a disease caused by allogenic substances like modeling agents or biopolymers that are foreign to the body.
 <xref rid="bib0165" ref-type="bibr">
  <sup>5</sup>
 </xref> Colchicine decreases the symptoms these patients have that are associated with inflammatory response, and some clinical manifestations such as arthralgia, headache, and pulmonary infiltrates. These patients experience clinical improvement, and the manifestations decrease in frequency.
</p>
